BIOREGENX, INC.
BIOREGENX, INC.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Investments | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | |||||
Assets Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Notes And Loans Receivable Net Noncurrent | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Other Accounts Payable And Accrued Liabilities | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Other Long Term Debt Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Finite Lived Intangible Assets Net | - | - | 1 | 1 | - | 0 | 10 | 10 | 11 | 0 | 0 | 0 | |||||
Other Notes Payable Current | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Goodwill | - | - | - | - | - | - | 7 | 7 | 7 | - | - | - | |||||
Assets | 0 | 0 | 1 | 1 | 0 | 1 | 17 | 18 | 19 | 1 | 0 | 0 | |||||
Long Term Debt Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Other Assets Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Accounts Payable Current | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 0 | 0 | |||||
Interest Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Notes And Loans Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - | |||||
Deferred Revenue Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Finite Lived Intangible Assets Accumulated Amortiz… | - | - | - | - | - | - | - | - | - | 0 | - | - | |||||
Long Term Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Liabilities | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 3 | 0 | 0 | |||||
Common Stock Value | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Preferred Stock Value | - | - | - | - | - | - | - | - | 0 | - | - | - | |||||
Additional Paid In Capital | 32 | 32 | 31 | 31 | 31 | 31 | 30 | 30 | 30 | 10 | 3 | 3 | |||||
Retained Earnings Accumulated Deficit | -37 | -37 | -36 | -36 | -36 | -36 | -17 | -17 | -16 | -13 | -3 | -3 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | - | 0 | - | -0 | -0 | 0 | -0 | 0 | 0 | -0 | - | - | |||||
Stockholders Equity | -5 | -5 | -4 | -4 | -4 | -3 | 14 | 14 | 15 | -2 | -3 | -3 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 1 | 1 | 0 | 1 | 17 | 18 | 19 | 1 | 0 | 0 | |||||
Debt Default Shortterm Debt Amount | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | |||||
Common Stock Shares Issued | 972 | 969 | 962 | 961 | 960 | 957 | 957 | 957 | 957 | 771 | 830 | 830 | |||||
Shares Outstanding | 972 | 969 | 962 | 961 | 960 | 957 | 957 | 957 | 957 | 771 | 830 | 830 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.78% | -15.56% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -60.48% | -47.46% | -38.14% | 13.33% | 94.44% | 11.11% | 18.18% | 17.27% | 9.09% | -13.46% | -11.06% | -26.92% |
| 2024 | -16.22% | 7.84% | -19.86% | 8.00% | 23.54% | 1.01% | 27.20% | 4.00% | -1.20% | 18.50% | -4.17% | 27.42% |
| 2023 | -16.53% | -15.96% | -24.87% | -37.25% | -41.18% | -57.35% | -12.97% | 95.82% | 82.77% | -29.75% | -16.42% | -52.56% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.05 | 0.06 | 0.07 | 0.06 | 0.08 | 0.08 | 0.11 | 0.10 | 0.14 | 0.23 | 0.00 | - | |||||
| Quick Ratio | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.04 | 0.08 | 0.00 | - | |||||
| Working Capital | -3.80M | -3.82M | -3.66M | -3.68M | -3.49M | -3.33M | -3.15M | -3.09M | -2.90M | -2.13M | -239.78K | - | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.07 | -1.09 | -1.32 | -1.31 | -1.14 | -1.15 | 0.28 | 0.26 | 0.23 | -1.42 | -0.09 | -0.09 | |||||
| Interest Coverage TTM | -13.25 | -13.99 | -210.16 | -216.47 | -240.18 | -311.96 | -65.28 | -96.48 | -1,012.07 | -411.89 | -517.53 | - | |||||
| Debt Ratio | 14.45 | 12.04 | 4.12 | 4.18 | 8.37 | 7.65 | 0.22 | 0.21 | 0.19 | 3.39 | 7.08 | 2.78 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 4.31 | 4.03 | 0.21 | 0.21 | 0.24 | 3.41 | 0.29 | 0.31 | 0.31 | 7.38 | 80.44 | - | |||||
| Days Sales Outstanding TTM | 3.05 | 5.38 | 7.76 | 2.90 | 1.77 | 9.33 | 2.77 | 1.45 | 1.41 | 11.19 | - | - | |||||
| Receivables Turnover TTM | 119.54 | 67.79 | 47.03 | 125.87 | 206.51 | 39.14 | 131.55 | 251.86 | 258.20 | 32.62 | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | - | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | - | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 81.90% | 81.08% | 78.14% | 77.46% | 72.88% | 70.87% | 67.00% | 65.43% | 66.95% | 67.76% | - | - | |||||
| Operating Profit Margin TTM | -62.37% | -67.08% | -965.35% | -938.92% | -862.06% | -972.75% | -182.13% | -246.70% | -218.49% | -99.92% | -116.97% | - | |||||
| Net Profit Margin TTM | -73.81% | -83.23% | -980.96% | -953.62% | -874.72% | -985.17% | -191.98% | -255.23% | -226.06% | -105.53% | -122.31% | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -23.43% | -20.75% | -24.56% | -26.79% | -20.09% | -31.40% | -6.43% | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -93.54% | -93.30% | 285.45% | 173.52% | 209.20% | 540.37% | 46.87% | - | - | - | - | - | |||||
| EPS Growth (1Y) | -93.62% | -93.45% | 283.71% | 172.76% | 148.01% | 336.08% | -4.51% | - | - | - | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -8.62 | -8.02 | -0.79 | -0.60 | -0.95 | -0.37 | -2.92 | -2.86 | -5.06 | -4.18 | -6.51 | - | |||||
| P/B TTM | -2.48 | -2.73 | -4.08 | -3.15 | -5.40 | -2.50 | 1.06 | 1.41 | 2.19 | -7.26 | -7.78 | -17.86 | |||||
| P/S TTM | 6.36 | 6.68 | 7.72 | 5.70 | 8.34 | 3.61 | 5.61 | 7.29 | 11.44 | 4.41 | 7.96 | - | |||||
| Market Cap | 11.23M | 12.38M | 14.89M | 11.51M | 19.24M | 8.46M | 14.35M | 20.09M | 33.01M | 15.03M | 21.77M | 46.09M | |||||
| Enterprise Value | 11.37M | 12.49M | 15.03M | 11.64M | 19.41M | 8.65M | 14.56M | 20.28M | 33.04M | 15.06M | 21.71M | 46.06M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -31.15K | -20.09K | -100.68K | -54.31K | -184.86K | -516.19K | -797.17K | -1.05M | -1.52M | -1.56M | -1.27M | - | |||||
| Net Debt | 136.76K | 112.44K | 134.12K | 133.29K | 173.60K | 196.20K | 212.18K | 192.20K | 35.84K | 24.60K | -57.96K | -29.51K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
BIOREGENX, INC. (BRGX) — SEC Financial Statements & Analysis
BIOREGENX, INC. (BRGX) is a services-computer programming, data processing, etc. company, incorporated in NV. BIOREGENX, INC. trades on OTC as: BRGX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BIOREGENX, INC. reported a -23.43% year-over-year revenue growth, a Gross Profit Margin of 81.90% (TTM), a Debt-to-Equity ratio of -1.07x, a Price-to-Sales (P/S) ratio of 6.36x (TTM), a Price-to-Book (P/B) ratio of -2.48 (TTM), at a market cap of $11.23M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -23.43%
- Gross Profit Margin TTM
- 81.90%
- Debt To Equity
- -1.07x
- P/S TTM
- 6.36x
- P/B TTM
- -2.48
- Market Cap
- $11.23M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BIOREGENX, INC. in?
BIOREGENX, INC. (BRGX) operates in the Services-Computer Programming, Data Processing, Etc. industry.
What is BRGX's market cap?
BIOREGENX, INC. (BRGX) has a market capitalization of $11.23M as of 2026-03-31.
What exchange does BRGX trade on?
BIOREGENX, INC. (BRGX) trades on the OTC.
Where is BIOREGENX, INC. incorporated?
BIOREGENX, INC. is incorporated in NV.